Pier 88 Investment Partners LLC Biomarin Pharmaceutical Inc Transaction History

Pier 88 Investment Partners LLC

  • $76.1 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$83.81 - $99.0 $5,866 - $6,930
70 Added 3.95%
1,840 $160,000
Q4 2023

Feb 09, 2024
SELL
$76.22 - $98.51 $198,172 - $256,126
-2,600 Reduced 59.5%
1,770 $170,000
Q3 2023

Nov 09, 2023
BUY
$85.07 - $94.48 $292,640 - $325,011
3,440 Added 369.89%
4,370 $386,000
Q2 2023

Aug 07, 2023
SELL
$86.68 - $100.3 $6,067 - $7,021
-70 Reduced 7.0%
930 $80,000
Q1 2023

May 09, 2023
BUY
$87.74 - $117.27 $87,740 - $117,270
1,000 New
1,000 $97,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Pier 88 Investment Partners LLC Portfolio

Follow Pier 88 Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier 88 Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier 88 Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email